Cargando…
TRPV1 Antagonist DWP05195 Induces ER Stress-Dependent Apoptosis through the ROS-p38-CHOP Pathway in Human Ovarian Cancer Cells
In addition to their analgesic activity, transient receptor potential vanilloid 1 (TRPV1) agonists and antagonists demonstrate profound anti-cancer activities in various human cancers. In the present study, we investigated the anti-cancer activity of a novel TRPV1 antagonist, DWP05195, and evaluated...
Autores principales: | Wang, Yi-Yue, Lee, Kyung-Tae, Lim, Myong Cheol, Choi, Jung-Hye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352786/ https://www.ncbi.nlm.nih.gov/pubmed/32604833 http://dx.doi.org/10.3390/cancers12061702 |
Ejemplares similares
-
A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers
por: Lee, Jieon, et al.
Publicado: (2017) -
In vivo depth-resolved oxygen saturation by dual-wavelength photothermal (DWP) OCT
por: Kuranov, Roman V., et al.
Publicado: (2011) -
Evaluation of safety and anti-obesity effects of DWP16001 in naturally obese dogs
por: Rhee, Beomseok, et al.
Publicado: (2022) -
In Vitro Metabolism of DWP16001, a Novel Sodium-Glucose Cotransporter 2 Inhibitor, in Human and Animal Hepatocytes
por: Kim, Ju-Hyun, et al.
Publicado: (2020) -
Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, with Dapagliflozin and Ipragliflozin
por: Choi, Min-Koo, et al.
Publicado: (2020)